From Information to Insight: A Decision Architecture for Informed Governance

For effective drug development governance, understanding risks and success likelihood is crucial for informed decision-making.Rayner et al. proposed a structured decision architecture that elevates risks to governance bodies and employs AI and expert judgment.This structure is valuable regardless of company size or portfolio.While it may not guarantee optimal decisions, it ensures decisions are made with comprehensive information and clear understanding of risks and assumptions.